A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile | MicrobiomeTrials← Back to trialsNCT07649096
A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09-17Est. Completion: 2028-08-22
Enrollment target: 86 participants Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis
Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative …
Roma, ItalyCompleted Feb 1, 2025
Hemodialysis
The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and …
Copenhagen, DenmarkEst. completion Oct 2028
Leukemia, Lymphocytic, Acute
Leukemia, Myeloid, Acute
Lymphoma
Clostridium Difficile Infection
Solid Cancers
The primary objective of the study is to determine whether dietary intervention to increase fiber and decrease fat reduc…
Aurora, United StatesCompleted Jul 2, 2025